Fulcrum Therapeutics Inc. (FULC) Misses Q1 EPS by 2c

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• IMF chief says global economy weathered Iran war shock well
• TD Cowen Reiterates Hold Rating on Intuit (INTU)